rs8191371

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_000175.5(GPI):​c.623T>C​(p.Ile208Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0206 in 1,614,108 control chromosomes in the GnomAD database, including 420 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I208V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.015 ( 24 hom., cov: 31)
Exomes 𝑓: 0.021 ( 396 hom. )

Consequence

GPI
NM_000175.5 missense

Scores

10
5
3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 8.02

Publications

16 publications found
Variant links:
Genes affected
GPI (HGNC:4458): (glucose-6-phosphate isomerase) This gene encodes a member of the glucose phosphate isomerase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In the cytoplasm, the gene product functions as a glycolytic enzyme (glucose-6-phosphate isomerase) that interconverts glucose-6-phosphate and fructose-6-phosphate. Extracellularly, the encoded protein (also referred to as neuroleukin) functions as a neurotrophic factor that promotes survival of skeletal motor neurons and sensory neurons, and as a lymphokine that induces immunoglobulin secretion. The encoded protein is also referred to as autocrine motility factor based on an additional function as a tumor-secreted cytokine and angiogenic factor. Defects in this gene are the cause of nonspherocytic hemolytic anemia and a severe enzyme deficiency can be associated with hydrops fetalis, immediate neonatal death and neurological impairment. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
GPI Gene-Disease associations (from GenCC):
  • hemolytic anemia due to glucophosphate isomerase deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, MutationAssessor, phyloP100way_vertebrate, PrimateAI, REVEL, REVEL [when BayesDel_addAF, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.01349929).
BP6
Variant 19-34377871-T-C is Benign according to our data. Variant chr19-34377871-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 402910.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0146 (2224/152256) while in subpopulation NFE AF = 0.0223 (1518/68014). AF 95% confidence interval is 0.0214. There are 24 homozygotes in GnomAd4. There are 1072 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPINM_000175.5 linkc.623T>C p.Ile208Thr missense_variant Exon 6 of 18 ENST00000356487.11 NP_000166.2 P06744-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPIENST00000356487.11 linkc.623T>C p.Ile208Thr missense_variant Exon 6 of 18 1 NM_000175.5 ENSP00000348877.3 P06744-1

Frequencies

GnomAD3 genomes
AF:
0.0146
AC:
2223
AN:
152138
Hom.:
24
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00488
Gnomad AMI
AF:
0.0461
Gnomad AMR
AF:
0.00884
Gnomad ASJ
AF:
0.0164
Gnomad EAS
AF:
0.000772
Gnomad SAS
AF:
0.0213
Gnomad FIN
AF:
0.0117
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0223
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0156
AC:
3931
AN:
251432
AF XY:
0.0161
show subpopulations
Gnomad AFR exome
AF:
0.00363
Gnomad AMR exome
AF:
0.00665
Gnomad ASJ exome
AF:
0.0173
Gnomad EAS exome
AF:
0.000979
Gnomad FIN exome
AF:
0.0134
Gnomad NFE exome
AF:
0.0218
Gnomad OTH exome
AF:
0.0151
GnomAD4 exome
AF:
0.0212
AC:
30980
AN:
1461852
Hom.:
396
Cov.:
32
AF XY:
0.0211
AC XY:
15355
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.00314
AC:
105
AN:
33480
American (AMR)
AF:
0.00655
AC:
293
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0178
AC:
464
AN:
26136
East Asian (EAS)
AF:
0.000907
AC:
36
AN:
39700
South Asian (SAS)
AF:
0.0191
AC:
1645
AN:
86256
European-Finnish (FIN)
AF:
0.0125
AC:
667
AN:
53418
Middle Eastern (MID)
AF:
0.0186
AC:
107
AN:
5768
European-Non Finnish (NFE)
AF:
0.0240
AC:
26653
AN:
1111974
Other (OTH)
AF:
0.0167
AC:
1010
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1743
3486
5228
6971
8714
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1002
2004
3006
4008
5010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0146
AC:
2224
AN:
152256
Hom.:
24
Cov.:
31
AF XY:
0.0144
AC XY:
1072
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00486
AC:
202
AN:
41544
American (AMR)
AF:
0.00883
AC:
135
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0164
AC:
57
AN:
3470
East Asian (EAS)
AF:
0.000773
AC:
4
AN:
5172
South Asian (SAS)
AF:
0.0220
AC:
106
AN:
4824
European-Finnish (FIN)
AF:
0.0117
AC:
124
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0223
AC:
1518
AN:
68014
Other (OTH)
AF:
0.0156
AC:
33
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
108
216
323
431
539
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0197
Hom.:
134
Bravo
AF:
0.0135
TwinsUK
AF:
0.0232
AC:
86
ALSPAC
AF:
0.0257
AC:
99
ESP6500AA
AF:
0.00545
AC:
24
ESP6500EA
AF:
0.0203
AC:
175
ExAC
AF:
0.0155
AC:
1885
Asia WGS
AF:
0.00982
AC:
34
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GPI: PP3, BS1, BS2 -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 1.5% of total chromosomes in ExAC, 2% (1358/66686) of European chromosomes -

Hemolytic anemia due to glucophosphate isomerase deficiency Benign:1
Nov 22, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

GPI-related disorder Benign:1
Mar 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Benign
-0.074
T
BayesDel_noAF
Pathogenic
0.14
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.93
.;.;D;D
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;D;.;D
MetaRNN
Benign
0.013
T;T;T;T
MetaSVM
Uncertain
0.63
D
MutationAssessor
Pathogenic
4.3
.;.;H;H
PhyloP100
8.0
PrimateAI
Pathogenic
0.83
D
PROVEAN
Uncertain
-4.2
.;.;.;D
REVEL
Pathogenic
0.74
Sift
Pathogenic
0.0
.;.;.;D
Sift4G
Pathogenic
0.0
.;.;.;D
Polyphen
0.98
.;.;D;D
Vest4
0.41
MPC
1.4
ClinPred
0.079
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
Varity_R
0.93
gMVP
0.95
Mutation Taster
=38/62
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8191371; hg19: chr19-34868776; COSMIC: COSV99066716; COSMIC: COSV99066716; API